Form 8-K Aravive, Inc. For: Aug 02

Go back to Form 8-K Aravive, Inc. For: Aug 02

Aravive Inc. (ARAV) to Resume Trading at 4:35 p.m. After Announcing Trial Fails

August 2, 2023 4:23 PM EDT

Aravive Inc. (NASDAQ: ARAV) to Resume Trading at 4:35 p.m. After Announcing Trial Fails

Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept in Platinum-Resistant Ovarian CancerTrial did not meet primary endpoint of progression-free survivalCash at the end... More